Dcvc Opportunity Fund Ii Gp, LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 2Value: $81.5MLatest: 2025Q1

DCVC Opportunity Fund II GP, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 2 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "RXRX",
  "RKLB"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 2
Total Value: 81483428
Accession Number: 0001104659-25-048969
Form Type: 13F-HR
CIK: dcvc-opportunity-fund-ii-gp
Manager Name: Dcvc-Opportunity-Fund-Ii-Gp

Data Enrichment

100% identified

2 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

2 positions • $81.5M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Rocket Lab USA, Inc.

RKLB|773122106

Shares:3.4M

Value:$60.6M

% of Portfolio:74.3% ($60.6M/$81.5M)

RECURSION PHARMACEUTICALS, INC.

RXRX|75629V104

Shares:4.0M

Value:$20.9M

% of Portfolio:25.7% ($20.9M/$81.5M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Rocket Lab USA, Inc.(RKLBcusip773122106)	3.4M	QoQ 0.00% (-0) YoY -52.96% (-3.8M)	All Managers (Combined)	$60.6M	74.3% ($60.6M/$81.5M)	QoQ -29.79% (-$25.7M) YoY +104.63% (-$31.0M)
RECURSION PHARMACEUTICALS, INC.(RXRXcusip75629V104)	4.0M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$20.9M	25.7% ($20.9M/$81.5M)	QoQ -21.74% (-$5.8M) YoY -46.94% (-$18.5M)